SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

10 Aug 2023 Evaluate
The sales for the June 2023 quarter moved down -37.68% to Rs. 404.23 millions as compared to Rs. 648.60 millions during the year ago period.The Net Loss for the quarter ended June 2023 is Rs. -68.03 millions as compared to Net Profit of Rs. 8.40 millions of corresponding quarter ended June 2022The Operating Profit of the company witnessed a decrease to 6.28 millions from 38.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 404.23 648.60 -37.68 404.23 648.60 -37.68 2226.85 2196.26 1.39
Other Income 96.95 58.80 64.88 96.95 58.80 64.88 282.42 276.43 2.17
PBIDT 6.28 38.90 -83.86 6.28 38.90 -83.86 18.82 268.93 -93.00
Interest 9.82 3.54 177.40 9.82 3.54 177.40 25.13 16.10 56.09
PBDT -66.08 35.36 -286.88 -66.08 35.36 -286.88 -6.31 252.83 -102.50
Depreciation 24.25 23.81 1.85 24.25 23.81 1.85 91.15 95.93 -4.98
PBT -90.33 11.55 -882.08 -90.33 11.55 -882.08 -97.46 156.90 -162.12
TAX -22.30 3.15 -807.94 -22.30 3.15 -807.94 -36.66 8.91 -511.45
Deferred Tax -7.28 1.05 -793.33 -7.28 1.05 -793.33 -30.94 5.20 -695.00
PAT -68.03 8.40 -909.88 -68.03 8.40 -909.88 -60.80 147.99 -141.08
Equity 498.87 498.87 0.00 498.87 498.87 0.00 498.87 496.74 0.43
PBIDTM(%) 1.55 6.00 -74.10 1.55 6.00 -74.10 0.85 12.24 -93.10

Viyash Scientific Share Price

208.35 1.05 (0.51%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×